Clinical parameters | EPCAM | |||
---|---|---|---|---|
Low | High | t/χ2/r | P | |
Age(yrs) | 56.85 ± 11.4 | 61.51 ± 12.22 | 4.787 | 0.0001 |
Gender | 0.805 | 0.370 | ||
Male | 257 (60.0%) | 171 (40.0%) | ||
Female | 97 (56.1%) | 76 (43.9%) | ||
Location | 10.37 | 0.006 | ||
Proximal | 37 (44.0%) | 47 (56.0%) | ||
Middle | 130 (58.3%) | 93 (41.7%) | ||
Distal | 187 (63.6%) | 107 (36.4%) | ||
Size | 40.47 | 0.0001 | ||
<5 cm | 244 (69.7%) | 106 (30.3%) | ||
≥5 cm | 110 (43.8%) | 141 (56.2%) | ||
Lauren classification | 198.1 | 0.0001 | ||
Intestinal | 261 (87.3%) | 38 (12.7%) | ||
Diffuse | 93 (30.8%) | 209 (69.2%) | ||
Histology | 3.136 | 0.371 | ||
Papillary adenocarcinoma | 20 (69.0%) | 9 (31.0%) | ||
Tubular adenocarcinoma | 254 (57.9%) | 185 (42.1%) | ||
Mucinous adenocarcinoma | 19 (51.4%) | 18 (48.6%) | ||
Signet-ring cell carcinoma | 61 (63.5%) | 35 (36.5%) | ||
Histologic differentiation | 6.323 | 0.097 | ||
Well | 12 (70.6%) | 5 (29.4%) | ||
Moderately | 113 (64.6%) | 62 (35.4%) | ||
Poorly | 227 (55.8%) | 180 (44.2%) | ||
Others | 2 (100.0%) | 0 (0.0%) | ||
Invasion depth | 107.1 | 0.0001 | ||
T1 | 73 (91.2%) | 7 (8.8%) | ||
T2 | 113 (80.1%) | 28 (19.9%) | ||
T3 | 160 (47.3%) | 178 (52.7%) | ||
T4 | 8 (19.0%) | 34 (81.0%) | ||
TNM stages | 201.6 | 0.0001 | ||
I | 119 (93.7%) | 8 (6.3%) | ||
II | 116 (85.9%) | 19 (14.1%) | ||
III | 99 (42.9%) | 132 (57.1%) | ||
IV | 20 (18.5%) | 88 (81.5%) | ||
Lymphatic metastasis | 119.1 | 0.0001 | ||
No | 193 (87.7%) | 27 (12.3%) | ||
Yes | 161 (42.3%) | 220 (57.5%) | ||
Regional lymph nodes | 182.6 | 0.0001 | ||
PN0 | 193 (87.7%) | 27 (12.3%) | ||
PN1 | 118 (59.6%) | 80 (40.4%) | ||
PN2 | 42 (31.1%) | 93 (68.9%) | ||
PN3 | 1 (2.1%) | 47 (97.9%) | ||
Distant metastasis | 53.42 | 0.0001 | ||
No | 332 (65.1%) | 178 (34.9%) | ||
Yes | 22 (24.2%) | 69 (75.8%) |